Approval · Notice of Compliance 36404 · 2025
AHZANTIVE: Notice of Compliance 36404
Issued November 19, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36404
- Date
- November 19, 2025
- Company
- Valorum Biologics LlcNew York, New York, United States
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Canadian reference product
- ELYEA
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AHZANTIVE | 02562928 | Approved |
Medicinal ingredients
- AFLIBERCEPT 2 MG per 0.05ML